This company offers at-home genetic testing kits that analyze DNA to provide personalized health reports. These reports offer insights into potential health risks and predispositions, empowering individuals and their physicians to make more informed healthcare decisions.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals lack easy access to comprehensive genetic information, hindering their ability to make informed healthcare decisions in consultation with their physicians. Traditional genetic testing can be costly and may not always provide easily interpretable results for personalized health strategies.
Solution
Kailos Genetics offers accessible precision medicine through advanced genetic sequencing and analysis. The company's CLIA-certified laboratory employs next-generation sequencing and TargetRich™ enrichment technology to analyze patient samples, providing comprehensive genetic information. Kailos Genetics offers customizable precision medicine sequencing panels designed for integration into existing healthcare workflows. The company delivers accurate and transparent genetic variation data in preferred formats, facilitating personalized healthcare strategies.
Target Audience
Kailos Genetics serves individuals seeking personalized healthcare strategies and healthcare providers aiming to optimize patient care through precision medicine.
Features
- Next-generation DNA sequencing for comprehensive genetic analysis
- TargetRich™ enrichment technology to target relevant genomic regions
- Expedio™ Hereditary Cancer Risk Testing to identify hereditary cancer mutations
- Inspexion™ Pharmacogenomic Testing to provide pharmacogenetics information
- Customizable data delivery options for seamless integration into health information systems
- CLIA-certified laboratory ensuring accurate and reliable results